Download App

Log in to access Online Inquiry
Company Overview More
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
CEO: Greenman, William M.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > CERS Cerus > Detailed Quotes

CERS Cerus

4.970+0.130+2.69%
Close 05/26 20:00 ET
High
5.045
Open
4.850
Turnover
11.29M
Low
4.850
Pre Close
4.840
Volume
2.27M
Market Cap
879.18M
P/E(TTM)
Loss
52wk High
8.055
Shares
176.90M
P/E(Static)
Loss
52wk Low
4.380
Float Cap
737.03M
Bid/Ask %
0.00%
Historical High
81.875
Shs Float
148.30M
Volume Ratio
0.81
Historical Low
0.550
Dividend TTM
--
Div Yield TTM
4600
P/B
11.07
Dividend LFY
--
Div Yield LFY
92555.33%
Turnover Ratio
1.53%
Amplitude
4.03%
Avg Price
4.976
Lot Size
1
Float Cap
737.03M
Bid/Ask %
0.00%
Historical High
81.875
Shs Float
148.30M
Volume Ratio
0.81
Historical Low
0.550
Dividend TTM
--
P/B
11.07
Dividend LFY
--
Turnover Ratio
1.53%
Amplitude
4.03%
Avg Price
4.976
Lot Size
1
Price Forecast

No Data

News

Comment